First patients to receive personalised cancer treatment in Oxford
The trial involves Isis spin-outs, the University and the Oxford University Hospitals NHS Trust.
The trial involves Isis spin-outs, the University and the Oxford University Hospitals NHS Trust.
Immunocore has entered into an oncology research collaboration and licensing agreement with MedImmune, the global biologics research and development arm of AstraZeneca.
Wellcome Trust's VC arm backs an Isis spinout developing a gene therapy for inherited blindness.
Oxford University Innovation announced that OxSonics has raised £2.7 million to develop therapeutic technology which uses ultrasound devices in combination with ultrasound-sensitive nanoparticles.
'Imagine a piece of software that would allow the soldiers, aid workers and government officials thrown together after a disaster to quickly and securely communicate with each other whatever device they hold in their hands....
Oxford Immunotec announces preliminary fourth quarter revenues
The Awards recognise and reward individuals and small teams who have harnessed the potential of their excellent research.
Acquisition by US games company Zynga one of the largest for a European spin out.
Next generation carbon nanomaterials such as graphene, carbon nanotubes and fullerenes, with their unique physical properties, have been hailed as “miracle materials”.
Oxford University Innovation spin-out Oxford Immunotec has received a 2014 Queen’s Award for Enterprise.